Smoking cue reactivity in adult smokers with and without depression: A pilot study

American Journal on Addictions

Volumn 21, Issue 2, 2012, Pages 136-144

  Weinberger, Andrea H ^a   McKee, Sherry A ^a   George, Tony P ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; EXPOSURE; FEMALE; HUMAN; LABORATORY TEST; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; PILOT STUDY; SMOKING; WITHDRAWAL SYNDROME;

ADULT; CASE-CONTROL STUDIES; CUES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SMOKING; TOBACCO USE DISORDER;

EID: 84857221174     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00203.x     Document Type: Article

References (60)

1. Lasser K, Boyd JW, Woolhander S, et al,. Smoking and mental illness: A population-based prevalence study. JAMA. 2000; 284: 2606-2610.
2. Dierker L, Donny E,. The role of psychiatric disorders in the relationship between cigarette smoking and DSM-IV nicotine dependence among young adults. Nicotine Tob Res. 2008; 10: 439-446. (Pubitemid 351385824)
3. Grant BF, Hasin DS, Chou P, et al,. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry. 2004; 61: 1107-1115.
4. Walsh Z, Epstein A, Munisamy G, et al,. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. J Addict Dis. 2008; 27: 65-72.
5. Anda RF, Williamson DF, Escobedo LG, et al,. Depression and the dynamics of smoking: A national perspective. JAMA. 1990; 264: 1541-1545. (Pubitemid 20303383)
6. Wilhelm K, Wedgwood L, Niven H, et al,. Smoking cessation and depression: Current knowledge and future directions. Drug Alcohol Rev. 2006; 25: 97-107. (Pubitemid 43308158)
7. Kinnunen T, Henning L, Nordstrom BL,. Smoking cessation in individuals with depression: Recommendations for treatment. CNS Drugs. 1999; 11: 93-103. (Pubitemid 29113638)
8. Ziedonis D, Hitsman B, Beckham JC, et al,. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008; 10: 1691-1715.
9. John U, Meyer C, Rumpf H-J, et al,. Smoking, nicotine dependence and psychiatric comorbidity-a population-based study including smoking cessation after three years. Drug Alcohol Depend. 2004; 76: 287-295. (Pubitemid 39556358)
10. Wiesbeck GA, Kuhl HC, Yaldizli O, et al,. WHO/ISBRA Study Group on Biological State and Trait Markers of Alcohol Use and Dependence. Tobacco smoking and depression-results from the WHO/ISBRA study. Neuropsychobiology 2008; 57: 26-31. (Pubitemid 351859330)
11. Breslau N, Johnson EO,. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health. 2000; 90: 1122-1127. (Pubitemid 30445368)
12. Breslau N, Kilbey MM, Andreski P,. Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. Am J Psychiatry. 1992; 149: 464-469.
13. Weinberger AH, Desai R, McKee SA,. Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol, and substance use disorders. Drug Alcohol Depend. 2010; 108: 7-12.
14. Pomerleau OF, Pomerleau CS, Mehringer AM, et al,. Nicotine dependence, depression, and gender: Characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tob Res. 2005; 7: 91-102. (Pubitemid 40613166)
15. Niaura R, Britt DM, Borrelli B, et al,. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999; 1: 251-257.
16. Piasecki TM,. Relapse to smoking. Clin Psychol Rev. 2006; 26: 196-215. (Pubitemid 43238388)
17. Carter BL, Tiffany ST,. Meta-analysis of cue-reactivity in addiction research. Addiction. 1999; 94: 327-340. (Pubitemid 29137413)
18. Shiffman S, Paty JA, Gnys M, et al,. First lapses to smoking: Within-subjects analysis of real-time reports. J Consult Clin Psychology. 1996; 64: 366-379. (Pubitemid 26131633)
19. Payne TJ, Smith PO, Adams SG, et al,. Pretreatment cue reactivity predicts end-of-treatment smoking. Addict Behav. 2006; 31: 702-710.
20. Abrams DB, Monti PM, Carey KB, et al,. Reactivity to smoking cues and relapse: Two studies of discriminant validity. Behav Res Ther. 1988; 26: 225-233.
21. Janes AC, Pizzagalli DA, Richardt S, et al,. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010; 67: 722-729.
22. Niaura R, Abrams DB, Monti PM, et al,. Reactivity to high risk situations and smoking cessation outcome. J Subst Abuse. 1989; 1: 393-405.
23. Weissman MM, Sholomakis D, Pottenger M, et al,. Assessing depressive symptoms in five psychiatric populations: A validation study. Epidemiology. 1977; 106: 203-214. (Pubitemid 8190169)
24. Robbins L, Wing J, Wittchen H, Helzer JE,. The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with difference diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988; 45: 1069-1077. (Pubitemid 19005460)
25. Sayette MA, Hufford MR,. Effects of cue exposure and deprivation on cognitive resources in smokers. J Abnorm Psychol. 1994; 103: 812-818. (Pubitemid 24349365)
26. Shadel WG, Niaura R, Abrams DB,. Effect of different cue stimulus delivery channels on craving reactivity: Comparing in vivo and video cues in regular cigarette smokers. J Behav Ther Exp Psychiatry. 2001; 32: 203-209. (Pubitemid 33713045)
27. Sayette MA, Griffin KM, Sayers WM,. Counterbalancing in smoking cue research: A critical analysis. Nicotine Tob Res. 2010; 12: 1068-1079.
28. Heatherton TF, Kozlowski LT, Frecker RC, et al,. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86: 1119-1127.
29. Sobell LC, Sobell MB, Leo GI, et al,. Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict. 1988; 83: 393-402.
30. Fonder MA, Sacco KA, Termine A, et al,. Smoking cue-reactivity in schizophrenia: Effects of a nicotinic receptor antagonist. Biol Psychiatry. 2005; 57: 802-808. (Pubitemid 40487925)
31. Hutchison KE, Niaura R, Swift R,. Smoking cues decrease prepulse inhibition of the startle response and increase subjective craving in humans. Exp Clin Psychopharmacol. 1999; 7: 250-256. (Pubitemid 29399028)
32. First MB, Spitzer RL, Gibbon M, et al,. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Press; 1997.
33. Beck AT, Steer RA, Garbin MG,. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988; 8: 77-100. (Pubitemid 18045797)
34. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56-62.
35. Szegedi A, Lörch B, Scheurich A, et al,. Cue exposure in alcohol dependent patients: Preliminary evidence for different types of cue reactivity. J Neural Transm. 2000; 107: 721-730. (Pubitemid 30364712)
36. Avants SK, Margolin A, Kosten TR, et al,. Differences between responders and nonresponders to cocaine cues in the laboratory. Addict Behav. 1995; 20: 215-225.
37. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM,. Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine Tob Res. 2005; 7: 421-429. (Pubitemid 41418715)
38. Hitsman B, Spring B, Pingitore R, et al,. Effect of tryptophan depletion on the attentional salience of smoking cues. Psychopharmacology. 2007; 192: 317-324. (Pubitemid 46701577)
39. Hutchison KE, Monti PM, Rosenhow DJ, et al,. Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology. 1999; 142: 139-143. (Pubitemid 29190848)
40. Rohsenow DJ, Monti PM, Hutchison KE, et al,. High-dose transdermal nicotine and naltrexone: Effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol. 2007; 15: 81-92.
41. Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A,. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction. 2009; 104: 653-660.
42. Sayette MA, Shiffman S, Tiffany ST, et al,. The measurement of drug craving. Addiction. 2000; 95 (Suppl 2): S189-S210. (Pubitemid 30650382)
43. Sayette MA, Martin CS, Wertz JM, et al,. A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction. 2001; 96: 1419-1432. (Pubitemid 32977081)
44. Perez GH, Nicolau JC, Romano BW, et al,. Depression: A predictor of smoking relapse in a 6-month follow-up after hospitalization for acute coronary syndrome. Eur J Cardiovasc Prev Rehabil. 2008; 15: 89-94. (Pubitemid 351263261)
45. Niaura R, Britt DM, Shadel WM, et al,. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001; 15: 13-17. (Pubitemid 32194935)
46. Cinciripini PM, Wetter DW, Fouladi RT, et al,. The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003; 71: 292-301. (Pubitemid 36323933)
47. Kassel JD, Stroud LR, Paronis CA,. Smoking, stress, and negative affect: Correlation, causation, and context across stages of smoking. Psychol Bull. 2003; 129: 270-304. (Pubitemid 38389556)
48. Strasser AA, Kaufmann V, Jepson C, et al,. Effects of different nicotine replacement therapies on postcessation psychological responses. Addict Behav. 2005; 30: 9-17. (Pubitemid 39550435)
49. Kenford SL, Smith SS, Wetter DW, et al,. Predicting relapse back to smoking: Contrasting affective and physical models of dependence. J Consult Clin Psychol. 2002; 70: 216-227. (Pubitemid 34150988)
50. Strong DR, Kahler CW, Leventhal AM, et al,. Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. Nicotine Tob Res. 2009; 11: 1142-1153.
51. Hall SM, Reus VI, Munoz RF, et al,. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998; 55: 683-690. (Pubitemid 28364383)
52. Evins AE, Culhane MA, Alpert JE, et al,. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008; 28: 660-666.
53. Spring B, Doran N, Pagoto S, et al,. Fluoxetine, smoking, and history of major depression: A randomized controlled trial. J Consult Clin Psychol. 2007; 75: 85-94.
54. Gravely-Witte S, Stewart DE, Suskin N, et al,. The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients. J Behav Med. 2009; 32: 478-490.
55. Husky MM, Mazure CM, Paliwal P, et al,. Gender differences in the comorbidity of smoking behavior and major depression. Drug Alcohol Depend. 2008; 93: 176-179. (Pubitemid 350236582)
56. Niaura R, Shadel WG, Abrams DB, et al,. Individual differences in cue reactivity among smokers trying to quit: Effects of gender and cue type. Addict Behav. 1998; 23: 209-224. (Pubitemid 28136010)
57. Field M, Duka T,. Cue reactivity in smokers: The effects of perceived cigarette availability and gender. Pharmacol Biochem Behav. 2004; 78: 647-652. (Pubitemid 38901032)
58. Heishman SJ, Lee DC, Taylor RC, et al,. Prolonged duration of craving, mood, and autonomic responses elicited by cues and imagery in smokers: Effects of tobacco deprivation and sex. Exp Clin Psychopharmacol. 2010; 18: 245-256.
59. Drobes DJ, Tiffany ST,. Induction of smoking urge through imaginal and in vivo procedures: Physiological and self-report manifestations. J Abnorm Psychol. 1997; 106: 15-25. (Pubitemid 27063188)
60. Niaura R, Abrams DB, Pedraza M, et al,. Smokers' reactions to interpersonal interaction cues and presentation of smoking cues. Addict Behav. 1992; 17: 557-566.